Carthera Receives FDA Breakthrough Device Designation for SonoCloud-9 System
June 22, 2022
Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to treat a wide range of brain diseases, announces today that its SonoCloud-9® system has been listed as a Breakthrough Device by ...
chat_bubble0 Comment
visibility110 Views
Blood Vessel Breakthrough Major Step Towards Alzheimers Treatment
June 22, 2022
A breakthrough in our understanding of Alzheimer’s disease has revealed changes to blood vessels in the brain, potentially presenting a path for developing new drugs to help fight the disease, according to research we funded ...
chat_bubble0 Comment
visibility62 Views
Neurovation Labs Awarded Additional Air Force Phase II Contract Worth $1.25M to Develop Tools to Mitigate PTSD and Other Brain Traumas
June 22, 2022
Neurovation Labs, Inc., a biotechnology company developing the first objective diagnostic and companion treatment for Post-traumatic Stress Disorder (PTSD), today announced that it has been awarded a second U.S. Air Force Small Business Innovation Research ...
chat_bubble0 Comment
visibility98 Views
Popular Posts
